Akebia Therapeutics, Inc.
US ˙ NasdaqCM ˙ US00972D1054

SecurityAKBA / Akebia Therapeutics, Inc.
InstitutionAlps Advisors Inc
Latest Disclosed Ownership218,070 shares
Latest Disclosed Value $ 303,117
Alps Advisors Inc reports 0.08% increase in ownership of AKBA / Akebia Therapeutics, Inc.

On May 8, 2026 - Alps Advisors Inc filed a 13F-HR form disclosing ownership of 218,070 shares of Akebia Therapeutics, Inc. (US:AKBA) valued at $303,117 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 217,891 shares of Akebia Therapeutics, Inc.. This represents a change in shares of 0.08% during the quarter. The current value of the position is $211,462 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F AKEBIA THREAPEUTICS COM 00972D105 218,070 179 0.08 303 -13.43 0.0013
2026-02-12 2025-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 217,891 91,830 72.85 351 1.74 0.0020
2025-11-05 2025-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 126,061 -15,603 -11.01 344 -33.20 0.0019
2025-08-11 2025-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 141,664 141,664 516 0.0030
2019-08-07 2019-06-30 13F AKEBIA THERAPEUT COMMON STOCK 00972D105 0 -282,329 -100.00 0 -100.00
2019-05-01 2019-03-31 13F AKEBIA THERAPEUT COMMON STOCK 00972D105 282,329 61,934 28.10 2,312 89.66 0.0164
2019-02-04 2018-12-31 13F AKEBIA THERAPEUT COMMON STOCK 00972D105 220,395 119,447 118.33 1,219 36.81 0.0095
2018-10-25 2018-09-30 13F AKEBIA THERAPEUT COMMON STOCK 00972D105 100,948 18,399 22.29 891 8.13 0.0058
2018-08-02 2018-06-30 13F/A-2 Akebia Therapeutics COMMON STOCK 00972D105 82,549 19,151 30.21 824 36.42 0.0054
2018-07-31 2018-06-30 13F/A-1 Akebia Therapeutics COMMON STOCK 00972D105 52,379 -30,170 779
2018-07-25 2018-06-30 13F Akebia Therapeutics COMMON STOCK 00972D105 52,379 -11,019 779
2018-05-01 2018-03-31 13F Akebia Therapeutics COMMON STOCK 00972D105 63,398 11,019 21.04 604 -22.46 0.0048
2018-02-20 2017-12-31 13F/A-1 Akebia Therapeutics COMMON STOCK 00972D105 52,379 6,007 12.95 779 -14.58 0.0054
2018-02-05 2017-12-31 13F Akebia Therapeutics COMMON STOCK 00972D105 52,379 6,007 779
2017-11-03 2017-09-30 13F Akebia Therapeutics COMMON STOCK 00972D105 46,372 11,323 32.31 912 80.95 0.0065
2017-08-03 2017-06-30 13F Akebia Therapeutics COMMON STOCK 00972D105 35,049 2,079 6.31 504 66.34 0.0035
2017-05-12 2017-03-31 13F Akebia Therapeutics COMMON STOCK 00972D105 32,970 -3,860 -10.48 303 -20.89 0.0021
2017-01-24 2016-12-31 13F Akebia Therapeutics Common Stock 00972D105 36,830 -11,630 -24.00 383 -12.76 0.0028
2016-11-02 2016-09-30 13F Akebia Therapuetics Common Stock 00972D105 48,460 -4,890 -9.17 439 10.03 0.0036
2016-07-27 2016-06-30 13F Akebia Therapuetics Common Stock 00972D105 53,350 10,728 25.17 399 3.91 0.0035
2016-05-10 2016-03-31 13F Akebia Therapuetics Common Stock 00972D105 42,622 2,270 5.63 384 -26.30 0.0040
2016-02-05 2015-12-31 13F Akebia Therapuetics Common Stock 00972D105 40,352 -4,785 -10.60 521 -88.05 0.0051
2015-11-13 2015-09-30 13F Akebia Therapuetics Common Stock 00972D105 45,137 16,533 57.80 4,360 1,382.99 0.0046
2015-08-12 2015-06-30 13F AKEBIA THERAPEUTICS Common Stock 00972D105 28,604 18,563 184.87 294 162.50 0.0025
2015-05-15 2015-03-31 13F AKEBIA THERAPEUTICS Common Stock 00972D105 10,041 10,041 112 0.0009
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.